On June 6, 2024, the Administrator of the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS)...
CDC Enhanced Summer 2024 Influenza Surveillance Strategy
read more
Contact Us: 1-800-981-9883
CDC LOCS
Select Agents and Toxins Exemption for H5 Avian Influenza Viruses
On June 3, 2024, the U.S. Centers for Disease Control and Prevention (CDC), in collaboration with the State, Tribal, Local, and Territorial (STLT)...
Enforcement Discretion Granted for the Use of Conjunctival Swabs with the CDC Human Influenza Virus Real-Time RT-PCR Diagnostic Panel, Influenza A/H5 Subtyping Kit
On May 24, 2024, the U.S. Food and Drug Administration (FDA) granted enforcement discretion for the use of conjunctival swabs as an acceptable...
CDC Issues Alert for Adverse Effects Linked to Counterfeit or Mishandled Botulinum Toxin Injections
On April 23, 2024, CDC issued a Health Alert Network (HAN) message about the risks of counterfeit or mishandled botulinum toxin injections. CDC, the...
Increase in Global and Domestic Measles Cases and Outbreaks: Ensure Children in the United States and Those Traveling Internationally 6 Months and Older are Current on MMR Vaccination
On March 18, 2024, the U.S. Centers for Disease Control and Prevention (CDC) issued a Health Alert Network (HAN) message to inform clinicians and...
Biosafety Laboratory Guidance for Handling and Processing Mpox Specimens
On April 4, 2024, the U.S. Centers for Disease Control and Prevention (CDC) updated the Biosafety Laboratory Guidance for Handling and Processing...
Highly Pathogenic Avian Influenza A(H5N1) Virus: Identification of Human Infection and Recommendations for Investigations and Response
On April 5, 2024, the U.S. Centers for Disease Control and Prevention (CDC) issued a Health Alert Network (HAN) message about a recently confirmed...
Upcoming CLIAC Meeting
On March 26, 2024, the Clinical Laboratory Improvement Advisory Committee (CLIAC) published information about the upcoming virtual CLIAC meeting,...
FDA Revokes EUAs for Six SARS-CoV-2 In Vitro Diagnostic Devices
On March 21, 2024, the U.S. Food and Drug Administration (FDA) published a notice in the Federal Register about the revocation of six Emergency Use...
Stay Informed!
Stay informed about the latest regulatory announcements, upcoming events, trending accreditation news and other laboratory topics.